BioCorRx Inc (BICX):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】BioCorRx Inc (BICX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C9443)・商品コード:DATA904C9443
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:45
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
BioCorRx Inc (BioCorRx), formerly Fresh Start Private Management Inc, is a healthcare solution provider. The company provides alcoholism and opioid addiction treatment program for use in rehabilitation and treatment centers. It distributes and licenses BioCorRx recovery program, a medication-assisted treatment (MAT) program that includes a counseling program coupled with its proprietary naltrexone implant. It also develops BICX101, an injectable naltrexone product; and BICX102, an implantable naltrexone implant for the treatment of alcohol and opioid addiction. The company distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. BioCorRx is headquartered in Anaheim, California, the US.

BioCorRx Inc (BICX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
BioCorRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
BioCorRx Inc, Medical Devices Deals, 2012 to YTD 2018 10
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
BioCorRx Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Biocorrx Acquires Portfolio from Therakine Biodelivery 12
BioCorRx Acquires Intellectual Property and Contractual Rights of Well Advised 13
Private Equity 14
Alpine Creek Capital Partners to Invest USD1.66 Million in BioCorRx 14
Partnerships 15
BioCorRx Enters into Licensing Agreement with Therakine 15
BioCorRx to Enter into Agreement with VDM Biochemicals 16
Licensing Agreements 17
BioCorRx Enters into Licensing Agreement with Fresh Start Private Midwest 17
Equity Offering 18
BioCorRx Raises USD1.1 Million in Private Placement of Units 18
Debt Offering 19
BioCorRx Raises USD0.08 Million in Private Placement of Note 19
BioCorRx Raises USD0.08 Million in Private Placement of Note 20
BioCorRx Raises USD0.3 Million in Private Placement of Note 21
BioCorRx Inc – Key Competitors 22
BioCorRx Inc – Key Employees 23
BioCorRx Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Product News 25
07/25/2017: BioCorRx Announces EnLite Clinics to Implement the BioCorRx Recovery Program in Three Clinics in Ohio 25
07/06/2017: BioCorRx to Exhibit at ASAM Conference in Dallas, Texas 26
05/22/2018: BioCorRx Announces Grant Submission to the National Institutes of Health for BICX102 27
04/30/2018: BioCorRx Gains Additional Media Coverage from Fox Medical Correspondent Who Discusses the Advantages of the Naltrexone Implant 28
04/26/2018: BioCorRx CEO Brady Granier and Actor Jeremy Miller Appear on Varney & Co. on Fox Business to Discuss the Company’s Sustained Release Naltrexone Implant for Alcohol Use Disorder 29
04/05/2018: BioCorRx Partner, Virtual Reality Medical Center, Submits Small Business Innovation Grant Application to the National Institute of Health 30
01/05/2018: BioCorRx Retains Regulatory Drug Expert Priya Jambhekar and CMC Expert Bruce Firestone 31
01/02/2018: BioCorRx CEO, Brady Granier, Appears on Fox & Friends to Discuss the Opioid Epidemic 32
Product Approvals 33
Feb 12, 2018: BioCorRx Announces Results of Pre-IND meeting with FDA for Sustained Release Naltrexone Implant, BICX102 33
Dec 19, 2017: BioCorRx Submits Pre-IND Package to FDA for its Naltrexone Implant, BICX102 34
Sep 28, 2017: BioCorRx Announces Update on Commercialization Efforts for Naltrexone Implant 35
Jan 12, 2017: BioCorRx Retains Innovative Science Solutions to Guide FDA Regulatory Process for its Naltrexone Products 36
Other Significant Developments 37
Apr 06, 2018: BioCorRx Provides Business Update for the Full Year Ended 2017 37
Mar 15, 2018: BioCorRx Provides Update on New Weight Management Program 39
Nov 17, 2017: BioCorRx Provides Business Update for the Third Quarter of 2017 40
Sep 12, 2017: BioCorRx Announces Beta Launch of Mobile Application for Opioid and Alcohol Substance Use Disorder 41
Aug 15, 2017: BioCorRx Reports 12% Increase in Revenue and Provides Business Update for the Second Quarter of 2017 42
Jul 31, 2017: Serrano Kidney and Vascular Access Center to Implement the BioCorRx Recovery Program for the Hispanic Market in Los Angeles 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
BioCorRx Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
BioCorRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
BioCorRx Inc, Deals By Therapy Area, 2012 to YTD 2018 9
BioCorRx Inc, Medical Devices Deals, 2012 to YTD 2018 10
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Biocorrx Acquires Portfolio from Therakine Biodelivery 12
BioCorRx Acquires Intellectual Property and Contractual Rights of Well Advised 13
Alpine Creek Capital Partners to Invest USD1.66 Million in BioCorRx 14
BioCorRx Enters into Licensing Agreement with Therakine 15
BioCorRx to Enter into Agreement with VDM Biochemicals 16
BioCorRx Enters into Licensing Agreement with Fresh Start Private Midwest 17
BioCorRx Raises USD1.1 Million in Private Placement of Units 18
BioCorRx Raises USD0.08 Million in Private Placement of Note 19
BioCorRx Raises USD0.08 Million in Private Placement of Note 20
BioCorRx Raises USD0.3 Million in Private Placement of Note 21
BioCorRx Inc, Key Competitors 22
BioCorRx Inc, Key Employees 23

List of Figures
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
BioCorRx Inc, Medical Devices Deals, 2012 to YTD 2018 10

★調査レポート[BioCorRx Inc (BICX):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C9443)販売に関する免責事項を必ずご確認ください。
★調査レポート[BioCorRx Inc (BICX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆